- Home
- Appointees
- Rahul Gupta
Rahul Gupta
Director · 2021–2025
Rahul Gupta, Director at the Office of National Drug Control Policy. 21 financial disclosure and ethics filings with the Office of Government Ethics, most recently Jan 18, 2025.
- Agency
- Office of National Drug Control Policy
- Ethics filings
- 21
- Latest filing
- Jan 18, 2025
Positions
- Director Office of National Drug Control Policy
Financial disclosure and ethics filings
- Nominee 278Jul 22, 2021
- Ethics AgreementJul 22, 2021
- Certificate of Divestiture OGE-2021-237Dec 10, 2021
- 278 TransactionMar 8, 2022
- 278 TransactionMay 17, 2022
- Annual (2022)May 24, 2022
- 278 TransactionJun 17, 2022
- 278 TransactionSep 23, 2022
- Certification of Ethics Agreement ComplianceSep 29, 2022
- 278 TransactionNov 15, 2022
- 278 TransactionDec 10, 2022
- 278 TransactionJan 31, 2023
- 278 TransactionMar 11, 2023
- 278 TransactionApr 4, 2023
- Annual (2023)May 20, 2023
- 278 TransactionMar 22, 2024
- Annual (2024)Jun 15, 2024
- 278 TransactionAug 1, 2024
- 278 TransactionAug 31, 2024
- 278 TransactionJan 11, 2025
- TerminationJan 18, 2025
Filed with the U.S. Office of Government Ethics. Form 278 reports list assets, income and debts; ethics agreements list what the official promised to sell or step away from.
More officials at the Office of National Drug Control Policy
- Michael Passante DAEO
- Anne Sokolov Certificate of Divestiture
- Anthony D Jones DAEO
More
From Senate roll call votes, Wikidata, Wikipedia and Office of Government Ethics records.
Cite or embed this page
Capitol Receipts, “Rahul Gupta: Director, Office of National Drug Control Policy,” https://www.capitolreceipts.com/appointee/oguptarahul/rahul-gupta (accessed 2026-10-13).